Table 2.
Patient | Eye | Visual acuity | Visual field progression | IOP (mmHg) | Number of medications taken | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||
Prepregnancy | 1st trimester | 2nd trimester | 3rd trimester | Postpartum | Prepregnancy | 1st trimester | 2nd trimester | 3rd trimester | Postpartum | ||||
1 | OD | 20/20 | No | 18 | 21 | 17 | 16 | 21 | 1 (L) | 0 | 0 | 0 | 0 |
OS | 20/20 | No | 18 | 21 | 15 | 14 | 20 | 1 (L) | 0 | 0 | 0 | 0 | |
2 | OD | 20/200 | Yes | 14 | 11 | 21 | 44 | 42 | 2 (L, T) | 1 (T) | 1 (T) | 1 (T) | 3 (L-T, AZ) |
3 | OD | 20/30 | No | 18 | 17 | 22 | 24 | 23 | 2 (T, B) | 1 (T) | 1 (T) | 1 (T) | 1 (T) |
OS | 20/40 | No | 16 | 20 | 18 | 25 | 23 | 2 (T, B) | 1 (T) | 1 (T) | 1 (T) | 1 (T) | |
4 | OD | 20/200 | No | 16 | _ | _ | 16 | 20 | 2 (L, T) | 2 (L, T) | 2 (L, T) | 1 (T) | 1 (T) |
5 | OD | 20/50 | No | 12 | 12 | 10 | 12 | 14 | 0 | 0 | 0 | 0 | 0 |
OS | CF | _ | 17 | 10 | 12 | 11 | 17 | 1 (T) | 0 | 0 | 0 | 0 | |
6 | OD | HM | _ | 22 | 20 | 23 | 24 | 16 | 2 (T, DZ) | 2 (T, DZ) | 1 (T) | 2 (T, DZ) | 2 (T, DZ) |
OS | 20/40 | No | 26 | 26 | 20 | 23 | 26 | 2 (T, DZ) | 2 (T, DZ) | 1 (T) | 2 (T, DZ) | 2 (T, DZ) | |
7 | OS | LP | _ | 16 | 16 | 23 | 16 | 13 | 1 (T) | 1 (T) | 1 (T) | 1 (T) | 1 (T) |
8 | OD | 20/20 | No | 18 | _ | _ | 23 | 28 | 1 (L) | 1 (L) | 1 (L) | 1 (T) | 2 (T, BZ) |
OS | 20/20 | No | 14 | _ | _ | 15 | 17 | 0 | 0 | 0 | 0 | 0 |
Abbreviations: IOP, intraocular pressure; L, latanoprost; T, timolol; T,DZ, timolol–dorzolamide, fixed combination; T,BZ, timolol–brinzolamide, fixed combination; L,T, latanoprost–timolol, fixed combination; T,B, timolol–brimonidine, fixed combination; AZ, azetazolamide; HM, hand movements; LP, light perception; CF, count fingers; OD, right eye; OS, left eye OU, both eyes.